jyoung
09-14-2009, 05:42 PM
Keryx Biopharmaceuticals (NASDAQ:KERX) zoomed to $1.63 with 22.56% gain and is trading with a massive volume of 2.43 million shares. The stock is amongst the top percentage gainer in the early morning trade. Today September 14, 2009, Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium…………….,
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!